ANGELA LAFONTAINE: Open Payments
NPI 1962154062 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,118 in 95 payments from 20 companies in 2025. Trend: 2023 $81 · 2024 $1,290 · 2025 $2,118
Food & beverage: $2,118
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $514 |
| Lilly USA, LLC | 7 | $230 |
| AstraZeneca Pharmaceuticals LP | 5 | $189 |
| ANI Pharmaceuticals, Inc. | 9 | $189 |
| Novo Nordisk Inc | 10 | $176 |
| Axsome Therapeutics, Inc. | 5 | $132 |
| Mallinckrodt Hospital Products Inc. | 4 | $119 |
| UCB, Inc. | 4 | $97 |
| Antares Pharma, Inc. | 4 | $88 |
| Janssen Biotech, Inc. | 4 | $73 |
Products named: RINVOQ, PURIFIED CORTROPHIN GEL, BREZTRI, Auvelity, ACTHAR, QULIPTA, ZEPBOUND, JARDIANCE.
Industry payments across MS — which companies pay providers there.
